Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases.
Pascal Morel, Pierre Fenaux(Saint Louis University Hospital), Claude Preudhomme(Centre Hospitalier Universitaire de Lille), J L Laï, Mohamed Hebbar, Alain Duhamel(Université de Lille), Eric Wattel(Université Claude Bernard Lyon 1), F Bauters(Centre Hospitalier Universitaire de Lille)
PubMed
September 1, 1993
Cited by 303
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.8k